Phillip Mertz
Vermogen: 1 M $ op 31-05-2026
Vermogen: 1 M $ op 31-05-2026
Phillip P.
Mertz is the founder of Secure Open Solutions.
Mr. Mertz is Chief Executive Officer at Subtle Technologies, Independent Director at Alpha Cognition, Inc., and Partner at Mertz Holdings.
Mr. Mertz was Director at Alpha Cognition, Inc. Mr. Mertz completed undergraduate studies at Harvard University in 2006.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ALPHA COGNITION INC 0,62% | 24-04-2026 | 135.503 ( 0,62% ) | 838 764 $ | 31-05-2026 |
ALPHA COGNITION, INC. 13,95% | 24-04-2026 | 44.160 ( 13,95% ) | 273 350 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ALPHA COGNITION INC. | Directeur/Bestuurslid | 18-03-2021 |
Secure Open Solutions | Oprichter | - |
Subtle Technologies | Algemeen Directeur | - |
Mertz Holdings
Mertz Holdings Financial ConglomeratesFinance Functions as an investment holding company | Corporate Officer/Principal | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Alpha Cognition, Inc. /old/
Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treating alzheimer disease and amyotrophic lateral sclerosis | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mertz Holdings
Mertz Holdings Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Alpha Cognition, Inc. /old/
Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treating alzheimer disease and amyotrophic lateral sclerosis | Health Technology |
Alpha Cognition, Inc.
Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases | Finance |
Secure Open Solutions | |
Subtle Technologies |
Kies jouw editie
Alle financiële informatie op nationaal niveau